AzTrials
AzTrials

Biochemical MarkersNCT06757699

Evaluation of Different Serum Cartilage Biomarkers in the Acute Response to Walking and Cycling in Healthy Male Subjects

A study testing Walking and Cycling in people with Biochemical Markers, run by Kocaeli University at 2 sites in Turkey (Türkiye).

Available

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The effect of physical activity on serum cartilage biomarkers is largely unknown. This study is critical to increase our knowledge of the physiological cartilage response to activities of daily living and dynamic tasks by focusing on healthy recreationally active individuals, thus improving our understanding of the… Read more about this study

Who is it for?
Ages 20 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Biochemical Markers
What is being tested?
Walking and Cycling
How many people
Not given
Where
2 sitesTurkey (Türkiye)
Study dates
Start not givento not given
Phase
Expanded access
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Healthy male volunteers between the ages of 20-35
  • Those who do physical activity for at least 30 minutes two to three days a week
  • 17 healthy male individuals without any health problems will be included.

Who cannot join

  • Those with acute or chronic injuries in their lower extremities
  • Those with musculoskeletal disorders in their lower extremities
  • Those who have undergone hip and/or knee surgery
  • Those with cardio-pulmonary problems that prevent them from exercising

Trial locations and contacts

2 sites in 1 country.

Turkey (Türkiye)2 sites
  • Kocaeli University Faculty of Medicine Hospital

    Kocaeli

    Available
  • Sakarya University Applied Sciences Physiotherapy and Rehabilitation Application and Research Center

    Sakarya

    Available

Other trials in Turkey (Türkiye)

About this study

The effect of physical activity on serum cartilage biomarkers is largely unknown. This study is critical to increase our knowledge of the physiological cartilage response to activities of daily living and dynamic tasks by focusing on healthy recreationally active individuals, thus improving our understanding of the complex relationship between cartilage health and the loading that occurs during different types of loading.

Read the detailed description

Biomarkers can be used to monitor cartilage metabolism and serve as prognostic or diagnostic markers to detect changes in joint structure (8). Most of these biomarkers are essential components of the cartilage extracellular matrix (ECM). The measurement of cartilage biomarkers is based on the principle that osmotic and mechanical loading triggers the efflux of proteolytically produced ECM fragments into the synovial fluid and then out of the joint capsule. Thus, biomarker concentrations can be measured by immunoassays in synovial fluid, blood, and urine. Similarly, biomarker concentrations have been used to investigate the acute or long-term effects of exercise on articular cartilage health and metabolism.

The most studied serum cartilage biomarker is cartilage oligomeric matrix protein (COMP). COMP, also known as thrombospondin-5, is a pentameric glycoprotein composed of five identical subunits. The C-terminal end of each monomer interacts with numerous KDHM proteins, such as collagen II, collagen IX, matrilins, and proteoglycans (9). In addition, COMP affects collagen secretion and fibrillogenesis, thereby influencing the rate of fibril formation, organization, and diameter (10). Due to these interactions with other KDHM proteins, COMP has an important role in the assembly and structure of the cartilage matrix, determining its mechanical properties.

Based on these properties, COMP has been widely studied in terms of acute loading and has been shown to be mechanosensitive (11). Serum COMP levels have been found to vary between -16% and +39% after 30 min of moderate running interventions (12). However, no increase in serum concentration was detected in response to other acute exercises, such as knee flexion or repeated lumbar flexion/extension (13). This suggests that the acute serum COMP response is dependent on joint loading characteristics.

Other biomarkers of interest are proteolytic enzymes involved in the degradation of cartilage KDHM components. Matrix metalloproteinases (MMPs) are a family of enzymes that vary in substrate specificity and primary structure.

Some MMP family members play a role in both KDHM remodeling and pathological degradation. For example, MMP-3 (stromelysin) degrades most components of KDHM and activates other MMPs such as MMP-9 (gelatinase B), which itself plays an important role in the development of OA (14).

YKL-40 is another KDHM protein involved in cartilage pathogenesis. Although the function of YKL-40 has not been defined in detail, it has been shown to be involved in general tissue remodeling and inflammatory processes as a glycosylase (15). YKL-40 levels increase during joint inflammation, and resistin levels are also elevated by inflammatory stimuli. Resistin is an adipokine that was initially associated with obesity and insulin resistance in rodents.

The response of MMPs, YKL-40, and resistin concentrations to exercise has been previously investigated. Marathon running has been shown to increase serum MMP-3 (+142%), YKL-40 (+56%), and resistin (+107%) concentrations immediately after the marathon compared to baseline values (16).

Type II collagen is a major component of articular cartilage. The degradation of type II collagen occurs via the activity of collagenases and MMP-9. Coll2-1 is a specific peptide epitope located on the triple helix of type II collagen molecules and is a marker of cartilage degeneration.

The nitrated form of Coll2-1 is called Coll2-1 NO2 and reflects oxidative-related cartilage matrix degradation. Serum concentrations of Coll2-1 (-13%) and Coll2-1 NO2 (-19%) have been shown to decrease after a marathon run (17).

Nagaoka et al. (18) evaluated the cartilage collagen metabolism of athletes exposed to intense joint loading. They measured both type II collagen synthesis and degradation biomarkers in urine. The results showed that type II collagen degradation increased in response to endurance exercises that included intense joint loading, especially in athletes who performed frequent jumping movements such as volleyball, basketball and handball.

The aim of our study was to examine the acute effect of two commonly used exercise interventions (walking and cycling) on the correlation of serum biomarkers reflecting cartilage extracellular matrix metabolism, COMP, YKL-40, and MMP3.

Being tested
Walking, Cycling
Keywords
serum cartilage, Osteoblastic activity, Osteoclastic activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WalkingOther

    Participants will perform 30 minutes of walking and cycling exercises. During the cycling and walking exercises, heart rate will be calculated using the Karvonen formula based on heart rate reserve.

    HRmax (maximum heart rate)=220-age HRR (%)(heart rate reserve)= (HR-HRrest)/(HRmax-HRrest)*100

    Blood samples will be collected from participants before starting the exercise, at the end of the 30-minute exercise session, and twice more at 30-minute intervals. The same participants will perform the cycling exercise half an hour later, and the same procedures will be applied.

  • CyclingOther

    Cycling

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Jan 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Expanded access
IDs, dates and publications
ClinicalTrials.gov ID
NCT06757699
Sponsor's protocol ID
Sakarya University of Applied
Status last verified
Jan 2026
First submitted
27 Dec 2024
Last updated
10 Jun 2026
Results posted
No

Questions about this trial

What is this clinical trial studying?

A study testing Walking and Cycling in people with Biochemical Markers, run by Kocaeli University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Oguzhan Demir (+90264 616 1614, oguzhandemir@subu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in